Interferon And Hematopoietic Growth Factors Therapy In Decompensated Cirrhosis: Suggested Recommendations

Authors: Fazal A. Danish, Salman S. Koul, Fazal R. Subhani, Ahmed Ehsan Rabbani, 5. Saeeda Yasmin

HUMAN GENETICS DIVISION, MP 808, SOUTHAMPTON GENERAL HOSPITAL, SOUTHAMPTON, UNITED KINGDOM
PAKISTAN INSTITUTE OF MEDICAL SCIENCES (PIMS), ISLAMABAD
HOLY FAMILY HOSPITAL, RAWALPINDI
FOUNDATION UNIVERSITY MEDICAL COLLEGE (FUMC), RAWALPINDI
DEPARTMENT OF SURGERY (UNIT-II), RAWALPINDI GENERAL HOSPITAL, RAWALPINDI.

Volume 15 | Issue 2

Published: November 12, 2026

Abstract

Decompensated cirrhosis has traditionally been considered a contraindication to interferon and ribavirin therapy. Whereas, the same may be true for advanced cirrhosis, which is only amenable to liver transplantation, there are reports in the literature in which antiviral therapy has been given in selected cases of early hepatic decompensation with reasonable results. Thus decompensation per se is no more an absolute contraindication to antiviral therapy. It, however, requires modifications in the dose regimen and close monitoring especially for the development of hematologic effects. In this article, the pros and cons of antiviral therapy in decompensated liver cirrhosis is given with special emphasis on how to avoid antiviral dose reductions/withdrawal secondary to the development of hematologic side effects by using hematopoietic growth factors (HGFs). At the end, suggested recommendations are given.

Keywords: Chronic hepatitis C. Decompensated Cirrhosis. Antiviral Therapy. Hematopoietic Growth Factors.

DOI: (All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.)

Download Full Text PDF